Cholestyramine and Glaucoma - a phase IV clinical study of FDA data

Summary:

Glaucoma is reported as a side effect among people who take Cholestyramine (cholestyramine), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Avonex, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Glaucoma when taking Cholestyramine. It is created by eHealthMe based on reports of 9,676 people who have side effects when taking Cholestyramine from the FDA, and is updated regularly.

What is Cholestyramine?

Cholestyramine has active ingredients of cholestyramine. It is often used in diarrhea. eHealthMe is studying from 9,893 Cholestyramine users. Check the latest studies of Cholestyramine.

What is Glaucoma?

Glaucoma (increased fluid pressure in the eye with vision loss) is found to be associated with 1,236 drugs and 1,653 conditions by eHealthMe. Check the latest studies of Glaucoma.

On Jul, 12, 2026

9,676 people reported to have side effects when taking Cholestyramine.
Among them, 21 people (0.22%) have Glaucoma.

Among these 21 people:

How long have people been on Cholestyramine when they have Glaucoma? *

What is the gender of people who have Glaucoma when taking Cholestyramine? *

female: 90 %
male: 10 %

What is the age of people who have Glaucoma when taking Cholestyramine? *

What are other drugs people take besides Cholestyramine? *

What are other side effects people have besides Glaucoma? *

Cataract (clouding of the lens inside the eye): 11 people, 52.38%
Memory Loss: 7 people, 33.33%
Anticonvulsant Drug Level Decreased: 7 people, 33.33%
Urinary Tract Infection: 7 people, 33.33%
Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 7 people, 33.33%
Confusional State: 7 people, 33.33%
Fainting (loss of consciousness and postural tone): 7 people, 33.33%
Seizures (abnormal excessive or synchronous neuronal activity in the brain): 7 people, 33.33%
Blindness: 6 people, 28.57%
Headache (pain in head): 5 people, 23.81%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 10 people, 47.62%
Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 14.29%
Allergy To Arthropod Sting: 2 people, 9.52%
Nervous System Disorder (a general class of medical conditions affecting the nervous system): 2 people, 9.52%
High Blood Pressure: 2 people, 9.52%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 2 people, 9.52%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 2 people, 9.52%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 2 people, 9.52%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 9.52%
Ocular Discomfort (a generic expression when there is lack of ease in/about the eyes): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Cholestyramine and have Glaucoma?

- Check whether Glaucoma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Cholestyramine:

Cholestyramine (9,893 reports)

Glaucoma treatments and more:

Glaucoma (61,926 reports)

Browse all side effects of Cholestyramine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Glaucoma:

Glaucoma (1,236 drugs)

Browse all the conditions that are associated with Glaucoma:

Glaucoma (1,653 conditions)

Related publications that referenced our studies

Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .
Hu CY, Lee BJ, Cheng HF, Wang CY, "Acetazolamide-related life-threatening hypophosphatemia in a glaucoma patient", Journal of glaucoma, 2015 Apr .

How the study uses the data?

The study uses data from the FDA. It is based on cholestyramine (the active ingredients of Cholestyramine) and Cholestyramine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.